For many individuals struggling with obesity, mental health challenges such as depression are a significant concern. Traditional treatments for depression often involve selective serotonin reuptake inhibitors (SSRIs) and other antidepressants. However, these medications can lead to weight gain, exacerbating the very condition that contributes to poor mental health. Now, emerging research suggests that GLP-1 receptor agonists , such as semaglutide (Ozempic, Wegovy) and tirzepa